4WARD, a phase 3 chronic neutropenia study, will start enrolling in the U.S. soon 

NOTICE

You are now leaving the Chronic Neutropenia Study website and entering a website that is not owned or controlled by X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc. makes no representation as to the accuracy of the information contained on websites we do not own or control. X4 Pharmaceuticals, Inc. does not recommend or endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.